EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways

Elisabetta Tortorella iD, Sabrina Giantulli, Alessandro Sciarra iD, Ida Silvestri iD

International Journal of Molecular Sciences · 20.01.2023 · 24 (3) · 2046

DOI: 10.3390/ijms24032046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.01.2023. Verfasst von Elisabetta Tortorella und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Prostatic Neoplasms, Castration-Resistant, Proto-Oncogene Proteins c-akt, Receptors, Androgen. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the most common cancer in men. The androgen receptor (AR) has a pivotal role in the pathogenesis and progression of PCa. Many therapies targeting AR signaling have been developed over the years. AR signaling inhibitors (ARSIs), including androgen synthesis inhibitors and AR antagonists, have proven to be effective in castration-sensitive PCa (CSPC) and improve survival, but men with castration-resistant PCa (CRPC) continue to have a poor prognosis. Despite a good initial response, drug resistance develops in almost all patients with metastatic CRPC, and ARSIs are no longer effective. Several mechanisms confer resistance to ARSI and include AR mutations but also hyperactivation of other pathways, such as PI3K/AKT/mTOR. This pathway controls key cellular processes, including proliferation and tumor progression, and it is the most frequently deregulated pathway in human cancers. A significant interaction between AR and the PI3K/AKT/mTOR signaling pathway has been shown in PCa. This review centers on the current scene of different AR and PI3K signaling pathway inhibitors, either as monotherapy or in combination treatments in PCa, and the treatment outcomes involved in both preclinical and clinical trials. A PubMed-based literature search was conducted up to November 2022. The most relevant and recent articles were selected to provide essential information and current evidence on the crosstalk between AR and the PI3K signaling pathways. The ClinicalTrials.gov registry was used to report information about clinical studies and their results using the Advanced research tool, filtering for disease and target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesProstatic Neoplasms, Castration-ResistantProto-Oncogene Proteins c-aktReceptors, AndrogenHumansMaleTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

PI3K/AKT/mTORPTENandrogen receptor signalingcombination therapyprostate cancer

Substanzen

AKT1 protein, humanAR protein, humanMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, AndrogenTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • Department of Urology, Sapienza University of Rome, Viale del Policlinico, 00161 Rome, Italy.

ORCID-Profile: Elisabetta Tortorella, Alessandro Sciarra, Ida Silvestri

Zitieren

APA

Tortorella, E., Giantulli, S., Sciarra, A., & Silvestri, I. (2023). AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways. International Journal of Molecular Sciences, 24(3), 2046. https://doi.org/10.3390/ijms24032046

Vancouver

Tortorella E, Giantulli S, Sciarra A, Silvestri I. AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways. International Journal of Molecular Sciences. 2023;24(3):2046. doi:10.3390/ijms24032046

BibTeX
@article{Tortorella2023,
  author = {Tortorella, Elisabetta and Giantulli, Sabrina and Sciarra, Alessandro and Silvestri, Ida},
  title = {AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2046},
  doi = {10.3390/ijms24032046}
}
Kostenlos starten →